Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun 15;108(3):369-370.
doi: 10.1111/cge.70000. Online ahead of print.

Diagnosis of Angelman Syndrome, With 66 Years of Delay, Using Hypothesis-Free DNA Methylation Profiling

Mathis Hildonen  1 , Marco Ferilli  2 , Ilona Krey  3 , Oona Kohnen  4 , Camilla Cappelletti  2 , Konrad Platzer  3 , Andrea Ciolfi  2 , Rami Abou Jamra  3 , Marco Tartaglia  2 , Zeynep Tümer  1
Affiliations

Diagnosis of Angelman Syndrome, With 66 Years of Delay, Using Hypothesis-Free DNA Methylation Profiling

Mathis Hildonen et al. Clin Genet. .

Abstract

Hypothesis-free DNA methylation profiling in a 66-year-old male with unexplained neurodevelopmental disorder enabled the exclusion of ZNF142-related disease (left panel) and led to a retrospective diagnosis of Angelman syndrome, highlighting the diagnostic potential of single-patient epigenetic screening (right panel).

Keywords: Angelman syndrome; DNAm signature; array; epigenetic; episignature; methylation; undiagnosed.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
(A) Exclusion of ZNF142‐related disorder. The patient (orange dot) clusters with the control samples (green dots), while the individuals with biallelic ZNF142 LoF variants cluster separately (red). (B) DNAm levels at the SNRPN/SNURF loci located within the AS‐associated region, chr15q11.2‐q13. The proband's DNAm level (red line) is markedly lower than those of the controls (dotted lines). Yellow line, the mean methylation of controls.
See this image and copyright information in PMC

References

    1. Christensen M. B., Levy A. M., Mohammadi N. A., et al., “Biallelic Variants in ZNF142 Lead to a Syndromic Neurodevelopmental Disorder,” Clinical Genetics 102, no. 2 (2022): 98–109. - PMC - PubMed
    1. Hildonen M., Ciolfi A., Ferilli M., et al., “Biallelic Loss‐Of‐Function Variants in ZNF142 Are Associated With a Robust DNA Methylation Signature Affecting a Limited Number of Genomic Loci,” European Journal of Human Genetics (2025), 10.1038/s41431-025-01876-z. - DOI - PMC - PubMed
    1. Fujimoto M., Nakamura Y., Hosoki K., et al., “Genotype‐Phenotype Correlation Over Time in Angelman Syndrome: Researching 134 Patients,” Human Genetics and Genomics Advances 5, no. 4 (2024): 100342. - PMC - PubMed
    1. Garg P., Jadhav B., Rodriguez O. L., et al., “A Survey of Rare Epigenetic Variation in 23,116 Human Genomes Identifies Disease‐Relevant Epivariations and CGG Expansions,” American Journal of Human Genetics 107, no. 4 (2020): 654–669. - PMC - PubMed

LinkOut - more resources